What a Pediatric Clinical Trial Is

Part of Pediatric Trials: Starting from where you are.

About 3 minutes. Free, in your language, no account needed.

This is general education about clinical research — not medical advice, and not a way to join a study. Talk to your own doctor about your situation.

A clinical trial is a planned study in people, designed to answer a question that nobody can yet answer.

A pediatric clinical trial is one that involves children. Everything that is true of research in general is true here, with extra rules on top.

Research, not routine care

A study exists to produce an answer. It is not a way of giving a child a treatment already known to work — if something is already known to work well, it does not need a study to prove it.

That does not make research a good thing or a bad thing. It makes it a different thing from routine care, with a different purpose.

The written plan, and who checks it

Every study has a written plan, usually called the protocol. It says what the study is asking, who can take part, what happens at each visit, what is measured, and what happens if something goes wrong.

Before anyone joins, an independent committee reviews it. Depending on where you live it is called an ethics committee, an institutional review board, or an IRB. For a study involving children, the international guideline ICH E11 says that the committee should include members, or consult experts, who are knowledgeable in pediatric ethical, clinical and psychosocial issues.

In other words: a study involving children is not meant to be reviewed only by people who think about adults.

The rule that comes before all the others

There is one principle in pediatric research that sits above the rest, and it is worth quoting.

The ICH E11(R1) Addendum, adopted in August 2017, states that "children should not be enrolled in a clinical study unless necessary to achieve an important pediatric public health need."

Read that again slowly. The starting position is not that children may be studied when it is convenient. The starting position is that they should not be, unless there is a real need that cannot be met another way.

The same section adds that where studies are needed, they should be conducted in children who have the disease or condition the treatment is intended for, unless an exception is justified.

What pediatric studies can be about

Not all of them test a new medicine. Studies may look at:

Transparency

The E11(R1) Addendum also addresses openness: it describes registration of trials on publicly accessible databases and the public availability of results, so that objective information reaches the people who need it and unnecessary studies are not repeated.

That means the answer a study produces is meant to be visible, whether or not it is the answer anyone hoped for.

In short